| Trade |
aceRNA Technologies Co., Ltd. |
| CEO |
Fumihiro Sugawa |
| External Directors |
Hirohide Saito (Professor, Kyoto University; Professor, University of Tokyo), Nobuhiro Yagi (Kyoto University Innovation Capital Co., Ltd.), Mikihiko Shinozaki (Mitsubishi UFJ Capital Co., Ltd.), Norihide Hayakawa (DCI Partners Co., Ltd.), Makoto (Mark) Ohori (UTokyo Innovation Platform Co., Ltd.) |
| Establishment |
April 2018 |
| Corporate Vision |
Contribute to Regenerative Medicine and Drug Development through the discovery of novel miRNA applications. |
| Mission |
To eradicate untreatable diseases. |
| Capital |
JPY 30,000,000 |
| Address |
Innovation Hub Kyoto, 46-29 Yoshida Shimoichi-cho, Sakyo-ku, Kyoto 606-8304 JAPAN |
| Number of Employees |
12 |
COMPANY OVERVIEW
